title: Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
authors.forename: Michel E
authors.initials: ME
authors.lastname: Safar
authors.forename: Albert
authors.initials: A
authors.lastname: Fournier
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D017311:Amlodipine / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000502:physiology*; D001262:Atenolol / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007190:Indapamide / Q000494:pharmacology; D020913:Perindopril / Q000494:pharmacology; D016016:Proportional Hazards Models; D015203:Reproducibility of Results; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D017311:Amlodipine; D001262:Atenolol; D007190:Indapamide; D020913:Perindopril